Harbourvest Partners LLC Trans Medics Group, Inc. Transaction History

Harbourvest Partners LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$12.58 - $26.94 $1.46 Million - $3.13 Million	-116,123 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$19.16 - $32.68 $2.22 Million - $3.79 Million	116,123 New	116,123 $2.23 Million
Q1 2020 May 14, 2020	SELL	$10.5 - $20.2 $125,275 - $241,006	-11,931 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$16.61 - $21.64 $198,173 - $258,186	11,931 New	11,931 $227,000

396

31.9M

466K

286K

Ticker TMDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 31,831,400
Market Cap $2.42B
Description
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...

Get notified when there are updates to the investment portfolio of Harbourvest Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Harbourvest Partners LLC with notifications on news.